These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


160 related items for PubMed ID: 18070130

  • 1. EUCAST technical note on fluconazole.
    European Committee on Antimicrobial Susceptibility Testing-Subcommittee on Antifungal Susceptibility Testing (EUCAST-AFST)Department of Haematology, UMC St Radboud, Radboud University, Nijmegen, The Netherlands..
    Clin Microbiol Infect; 2008 Feb; 14(2):193-5. PubMed ID: 18070130
    [No Abstract] [Full Text] [Related]

  • 2. Correlation of the MIC and dose/MIC ratio of fluconazole to the therapeutic response of patients with mucosal candidiasis and candidemia.
    Rodríguez-Tudela JL, Almirante B, Rodríguez-Pardo D, Laguna F, Donnelly JP, Mouton JW, Pahissa A, Cuenca-Estrella M.
    Antimicrob Agents Chemother; 2007 Oct; 51(10):3599-604. PubMed ID: 17646421
    [Abstract] [Full Text] [Related]

  • 3. Emergency of fungemia cases caused by fluconazole-resistant Candida auris in Beijing, China.
    Chen Y, Zhao J, Han L, Qi L, Fan W, Liu J, Wang Z, Xia X, Chen J, Zhang L.
    J Infect; 2018 Dec; 77(6):561-571. PubMed ID: 30219662
    [Abstract] [Full Text] [Related]

  • 4. Community-acquired fungemia due to a multiple-azole-resistant strain of Candida tropicalis.
    Jandourek A, Brown P, Vazquez JA.
    Clin Infect Dis; 1999 Dec; 29(6):1583-4. PubMed ID: 10585825
    [No Abstract] [Full Text] [Related]

  • 5. In vitro susceptibility of breakthrough Candida bloodstream isolates correlates with daily and cumulative doses of fluconazole.
    Clancy CJ, Staley B, Nguyen MH.
    Antimicrob Agents Chemother; 2006 Oct; 50(10):3496-8. PubMed ID: 17005842
    [Abstract] [Full Text] [Related]

  • 6. Pharmacological advances in the treatment of invasive candidiasis.
    Deck DH, Guglielmo BJ.
    Expert Rev Anti Infect Ther; 2006 Feb; 4(1):137-49. PubMed ID: 16441215
    [Abstract] [Full Text] [Related]

  • 7. Candida parapsilopsis fungemias in bone marrow transplant recipients: implications for azole prophylactic therapy.
    López-Jiménez J, Duarte-Palomino R, Cabezudo E, Velasco-Martínez JJ, Sousa A, Odriozola J.
    Blood; 1997 May 01; 89(9):3491-2. PubMed ID: 9129061
    [No Abstract] [Full Text] [Related]

  • 8. Species distribution and fluconazole susceptibility of Candida clinical isolates in a medical center in 2002.
    Wang JL, Chang SC, Hsueh PR, Chen YC.
    J Microbiol Immunol Infect; 2004 Aug 01; 37(4):236-41. PubMed ID: 15340652
    [Abstract] [Full Text] [Related]

  • 9. Antifungal activities of R-135853, a sordarin derivative, in experimental candidiasis in mice.
    Kamai Y, Kakuta M, Shibayama T, Fukuoka T, Kuwahara S.
    Antimicrob Agents Chemother; 2005 Jan 01; 49(1):52-6. PubMed ID: 15616275
    [Abstract] [Full Text] [Related]

  • 10. Comparison of the efficacy of cilofungin, fluconazole and amphotericin B in the treatment of systemic Candida albicans infection in the neutropenic mouse.
    Bannatyne RM, Cheng PC, Fong IW.
    Infection; 1992 Jan 01; 20(3):168-70. PubMed ID: 1644494
    [Abstract] [Full Text] [Related]

  • 11. Wild-type MIC distributions, epidemiological cutoff values and species-specific clinical breakpoints for fluconazole and Candida: time for harmonization of CLSI and EUCAST broth microdilution methods.
    Pfaller MA, Andes D, Diekema DJ, Espinel-Ingroff A, Sheehan D, CLSI Subcommittee for Antifungal Susceptibility Testing.
    Drug Resist Updat; 2010 Dec 01; 13(6):180-95. PubMed ID: 21050800
    [Abstract] [Full Text] [Related]

  • 12. Fluconazole failure in two cases of disseminated candidosis.
    Jahnson L, Chryssanthou E, Petrini B, Vikerfors T.
    Scand J Infect Dis; 1995 Dec 01; 27(4):421-4. PubMed ID: 8658085
    [Abstract] [Full Text] [Related]

  • 13. [Profile of antifungal susceptibility of species of Candida isolated from hemocultures in a university hospital, Maracaibo, Venezuela].
    Arcaya NM, Mesa LM, Pineda MR, Beltrán-Luengo H, Milagros Calvo B.
    Rev Iberoam Micol; 2006 Jun 01; 23(2):97-100. PubMed ID: 16854186
    [Abstract] [Full Text] [Related]

  • 14. Clinical applicability of antifungal susceptibility testing on non-Candida albicans species in hospitalized patients.
    Wong-Beringera A, Hindler J, Brankovic L, Muehlbauer L, Steele-Moore L.
    Diagn Microbiol Infect Dis; 2001 Jan 01; 39(1):25-31. PubMed ID: 11173188
    [Abstract] [Full Text] [Related]

  • 15. Triazole-resistant candidaemia following posaconazole exposure.
    Weiler S, Lass-Flörl C, Auberger J, Bellmann-Weiler R, Stein M, Joannidis M, Bellmann R.
    Int J Antimicrob Agents; 2009 May 01; 33(5):494-5. PubMed ID: 19153033
    [No Abstract] [Full Text] [Related]

  • 16. Pattern of Candida isolates in hospitalized children.
    Saha R, Das Das S, Kumar A, Kaur IR.
    Indian J Pediatr; 2008 Aug 01; 75(8):858-60. PubMed ID: 18769898
    [Abstract] [Full Text] [Related]

  • 17. Species distribution and antifungal susceptibility patterns of clinical Candida isolates in North Lebanon: A pilot cross-sectional multicentric study.
    Osman M, Al Bikai A, Rafei R, Mallat H, Dabboussi F, Hamze M.
    J Mycol Med; 2020 Sep 01; 30(3):100986. PubMed ID: 32417178
    [No Abstract] [Full Text] [Related]

  • 18. Take control over your fluconazole prescriptions: the growing importance of Candida glabrata as an agent of candidemia in Brazil.
    Pasqualotto AC, Zimerman RA, Alves SH, Aquino VR, Branco D, Wiltgen D, do Amaral A, Cechinel R, Colares SM, da Rocha IG, Severo LC, Sukiennik TC.
    Infect Control Hosp Epidemiol; 2008 Sep 01; 29(9):898-9. PubMed ID: 18785850
    [No Abstract] [Full Text] [Related]

  • 19. Distribution and antifungal susceptibility of Candida species causing candidemia from 1996 to 1999.
    Cheng MF, Yu KW, Tang RB, Fan YH, Yang YL, Hsieh KS, Ho M, Lo HJ.
    Diagn Microbiol Infect Dis; 2004 Jan 01; 48(1):33-7. PubMed ID: 14761719
    [Abstract] [Full Text] [Related]

  • 20. Prior antimicrobial exposure and the risk for bloodstream infection with fluconazole-non-susceptible Candida strains.
    Hebert C, Villaran R, Tolentino J, Best L, Boonlayangoor S, Pitrak D, Lin M, Weber SG.
    Scand J Infect Dis; 2010 Jul 01; 42(6-7):506-9. PubMed ID: 20370357
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.